Product
Brinzolamide
Aliases
brinzolamide 1% ophthalmic suspension, Brinzolamide ophthalmic suspension
5 clinical trials
5 indications
Indication
Primary Open Angle GlaucomaIndication
ocular hypertensionIndication
GlaucomaIndication
Open Angle or Ocular HypertensionIndication
Open-AngleClinical trial
Therapeutic Equivalence Study of Generic Brinzolamide 1% Ophthalmic Suspension Compared to Reference Listed Drug Azopt® (Brinzolamide) Ophthalmic Suspension 1% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension.Status: Completed, Estimated PCD: 2022-12-29
Clinical trial
Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide Ophthalmic Suspension 1% to Azopt® in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both EyesStatus: Completed, Estimated PCD: 2020-02-26
Clinical trial
A BIOEQUIVALENCE STUDY OF THE GENERIC BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION COMPARED TO REFERENCE LISTED DRUG AZOPT® (BRINZOLAMIDE) OPHTHALMIC SUSPENSION 1% IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSIONStatus: Completed, Estimated PCD: 2018-11-17
Clinical trial
Stop Retinal Ganglion Cell Dysfunction StudyStatus: Active (not recruiting), Estimated PCD: 2024-07-01